# Digma System First in Human (FIH) Study

> **NCT07331857** · NA · NOT_YET_RECRUITING · sponsor: **Digma Medical Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Barrett's Esophagus (BE)

## Interventions

- **DEVICE:** Endoscopic Gastrointestinal Ablation Device (EGAD)

## Key facts

- **NCT ID:** NCT07331857
- **Lead sponsor:** Digma Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07331857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07331857, "Digma System First in Human (FIH) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07331857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*